Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Selinexor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03661515
What this trial is testing

Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML

Who this might be right for
Acute Myeloid Leukemia
PETHEMA Foundation 16
Not applicableActive Not RecruitingNCT06452446
What this trial is testing

Telehealth-based Symptom Management for Veterans Treated With Selinexor

Who this might be right for
Multiple MyelomaLarge-cell Lymphoma
Durham VA Medical Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT07437170
What this trial is testing

Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML

Who this might be right for
Acute Myeloid LeukemiaPediatric Acute Myeloid LeukemiaNUP98 Fusion-positive Acute Myeloid Leukemia
The Children's Hospital of Zhejiang University School of Medicine 10
Early research (Phase 1)Study completedNCT02299518
What this trial is testing

Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Alice Mims 23
Testing effectiveness (Phase 2)UnknownNCT04138381
What this trial is testing

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

Who this might be right for
Maximum Tolerated DoseGISTMetastatic Adult Soft Tissue Sarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 30
Not applicableUnknownNCT05559788
What this trial is testing

Real-World Use of Selinexor, Daratumumab and Dexamethasone in Chinese Patients With Multiple Myeloma at First Relapse

Who this might be right for
Multiple Myeloma at First Relapse
Fu chengcheng PhD 34
Early research (Phase 1)Study completedNCT02741388
What this trial is testing

A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP

Who this might be right for
B-cell Lymphoma
The Lymphoma Academic Research Organisation 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04764942
What this trial is testing

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 39
Testing effectiveness (Phase 2)Ended earlyNCT04768881
What this trial is testing

Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma

Who this might be right for
Locally Advanced Unresectable or Metastatic Melanoma
Karyopharm Therapeutics Inc 15
Testing effectiveness (Phase 2)WithdrawnNCT02431351
What this trial is testing

Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients

Who this might be right for
Myelodysplastic Syndrome
Karyopharm Therapeutics Inc
Early research (Phase 1)Study completedNCT02471911
What this trial is testing

KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Weill Medical College of Cornell University 22
Testing effectiveness (Phase 2)Looking for participantsNCT05736965
What this trial is testing

Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Shanghai Tong Ren Hospital 58
Early research (Phase 1)Study completedNCT03042819
What this trial is testing

Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas

Who this might be right for
Soft Tissue Sarcoma
University Health Network, Toronto 25
Testing effectiveness (Phase 2)Study completedNCT02186834
What this trial is testing

Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 28
Testing effectiveness (Phase 2)Looking for participantsNCT06556199
What this trial is testing

Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma

Who this might be right for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 38
Large-scale testing (Phase 3)Active Not RecruitingNCT05611931
What this trial is testing

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Karyopharm Therapeutics Inc 257
Early research (Phase 1)Active Not RecruitingNCT04216329
What this trial is testing

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GliosarcomaNewly DiagnosedGlioblastoma
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Looking for participantsNCT05698147
What this trial is testing

Selinexor in Combination With MTX+Ritu to Treat R/R CNSL

Who this might be right for
Central Nervous System Lymphoma
Tong Chen, MD 30
Early research (Phase 1)Active Not RecruitingNCT07094464
What this trial is testing

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

Who this might be right for
TP53-mutated MDS and AMLAllogeneic Hematopoietic Stem Cell Transplantation
Daihong Liu 20
Testing effectiveness (Phase 2)UnknownNCT05422027
What this trial is testing

Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Xia Zhongjun 42
Next Page